What were the five biggest stories of the week? Here’s what visitors to @AuManufacturing were reading. 5) New report estimates $220 million in economic activity, $4.8 billion in potential “pandemic preparedness benefit” generated through from Moderna factory Oxford Economics modelling commissioned by Moderna has predicted that the US biotech company’s Melbourne mRNA facility will add $220 million…
Oxford Economics modelling commissioned by Moderna has predicted that the US biotech company’s Melbourne mRNA facility will add $220 million annually to Australian GDP, support 990 ongoing jobs, and deliver “pandemic preparedness benefits” worth as much as $4.8 billion over 30 years “based on the likelihood of a future pandemic”. The Moderna Technology Centre in…
Moderna has opened the Southern Hemisphere’s only mRNA vaccine manufacturing site in Victoria, aiming to make 100 million doses a year.
The federal government has released Australia’s RNA Blueprint, which it says will “guide advanced manufacturing growth and help create more high-paying jobs” within a sector estimated to add “up to $8 billion” to national GDP over the next decade. In a statement on Tuesday, industry minister Ed Husic said the blueprint (available here) focussed on…
More rocket launches planned for Koonibba Test Range German rocket manufacturer Hyimpulse is negotiating further space launches from Southern Launch’s South Australian launch facilities following the successful launch its SL1 sub-orbital vehicle from the Koonibba Test Range near Ceduna, SA (pictured). The launch tested Hyimpulse’s novel propulsion technology. The company now plans further launches from…
Drug development company IDT Australia and pharmaceutical business Sanofi have signed an agreement for the good manufacturing practice (cGMP) manufacture of Sanofi’s mRNA vaccines now under development. The partners will collaborate to advance mRNA-based vaccine formulation, development and manufacture at IDT’s aseptic sterile injectables filling facilities in Melbourne (pictured) in volumes needed for clinical trials…
Envirostream to recycle LG lithium batteries Battery recycler Envirostream has signed an exclusive three year agreement with LG Energy Solutions to recycle all its recalled lithium ion batteries collected in Australia. Envirostream, a subsidiary of Lithium Australia, expects significantly increased battery collection volumes equating to 140 percent of the company’s total in FY23. LG has…
US-based biotech company Moderna has announced the launch of the mRNA Platform Incubator Network, linking Australian organisations with strength in translational and pharmaceutical science, early-phase clinical trials and regulatory science. According to the maker of the Spikevax COVID‑19 vaccine, the group aims to “advance mRNA medicine, foster scientific excellence in clinical translation in Australia and…
What were the five biggest stories of the week? Here’s what visitors to this site were reading. 5) Another battery metals factory lost offshore, more to come While Australia talks the big talk about being a critical minerals and battery metals superpower, backed by the $15 billion National Reconstruction Fund, Australian metals companies continue to…
The Victorian government has announced that construction of Moderna’s mRNA vaccine manufacturing facility is ahead of schedule and at the halfway mark, with completion expected next year. State industry minister Ben Carroll visited Monash University’s Clayton precinct on Monday morning, where the US-based biotechnology company will eventually have capacity for 100 million vaccine doses per…